Stockscreener 앱 받기
88.76
0.69%
-0.58
전일 마감가:
$89.34
열려 있는:
$88.6
하루 거래량:
385.52K
Relative Volume:
0.12
시가총액:
$35.80B
수익:
$4.03B
순이익/손실:
$576.20M
주가수익비율:
62.07
EPS:
1.43
순현금흐름:
$630.70M
1주 성능:
-0.39%
1개월 성능:
+2.79%
6개월 성능:
+21.21%
1년 성능:
-23.77%
1일 변동 폭
$87.56
$89.17
1주일 범위
$87.56
$93.25
52주 변동 폭
$62.34
$142.00
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
88.72 | 35.80B | 4.03B | 576.20M | 630.70M | 1.43 |
|
ABT
Abbott Laboratories
|
134.41 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.35 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
385.49 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.59 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.02 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Glucose Biosensor Market to Witness Remarkable Growth with Abbott Laboratories, Dexcom, F. Hoffmann-La Roche - EIN News
Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their Forecasts - Simply Wall St
Ownership Capital B.V. Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Principal Financial Group Inc. Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Peregrine Capital Management LLC Sells 29,135 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Lost Money on DexCom, Inc.(DXCM)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire
Alberta Investment Management Corp Acquires 36,500 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Lyell Wealth Management LP Has $4.71 Million Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Congress Asset Management Co. Increases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by GAM Holding AG - MarketBeat
Kornitzer Capital Management Inc. KS Has $4.34 Million Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Chevy Chase Trust Holdings LLC Sells 9,886 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Leerink Partnrs Has Bullish Forecast for DexCom Q1 Earnings - MarketBeat
Morgan Stanley Issues Positive Forecast for DexCom (NASDAQ:DXCM) Stock Price - MarketBeat
Is DexCom, Inc. (DXCM) the Best IoT Stock to Buy According to Analysts? - Insider Monkey
Cardinal Capital Management Invests $3.46 Million in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Van ECK Associates Corp Increases Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Banque Pictet & Cie SA Acquires 14,419 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Kestra Private Wealth Services LLC Grows Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Position Lessened by Compagnie Lombard Odier SCmA - MarketBeat
DexCom (NASDAQ:DXCM) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
DexCom's SWOT analysis: stock faces challenges amid growth potential - Investing.com India
Baillie Gifford & Co. Has $1.14 Billion Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Rhumbline Advisers Reduces Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Vontobel Holding Ltd. Trims Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Louisiana State Employees Retirement System Sells 3,700 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock - MarketBeat
Empire Life Investments Inc. Raises Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
New York State Teachers Retirement System Cuts Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Asset Management One Co. Ltd. Has $19.53 Million Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Q4 2024 Earnings Call Transcript - MSN
DexCom Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
3,145 Shares in DexCom, Inc. (NASDAQ:DXCM) Acquired by Angeles Wealth Management LLC - MarketBeat
Equitable Trust Co. Has $925,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Savant Capital LLC Has $8.58 Million Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom’s Optimistic Earnings Call: Growth Amid Challenges - TipRanks
DexCom Inc. stock outperforms competitors on strong trading day - MSN
DexCom (NASDAQ:DXCM) Stock Quotes, Forecast and News Summary - Benzinga
DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationDXCM - ACCESS Newswire
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom - Benzinga
Meta Platforms, Dexcom, Dell - TradingView
DexCom Unusual Options Activity - Benzinga
DexCom, Inc.'s (NASDAQ:DXCM) Intrinsic Value Is Potentially 38% Above Its Share Price - Simply Wall St
DexCom stock target raised to $100 by Bernstein analysts - Investing.com Nigeria
DexCom Likely to Sustain Stability in 2025, Morgan Stanley Says -February 14, 2025 at 12:12 pm EST - Marketscreener.com
DexCom Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart
DexCom Analysts Increase Their Forecasts After Q4 Earnings - Benzinga
Piper Sandler Adjusts Price Target on DexCom to $100 From $90 -February 14, 2025 at 08:45 am EST - Marketscreener.com
Wells Fargo Adjusts Price Target on DexCom to $98 From $94 -February 14, 2025 at 08:45 am EST - Marketscreener.com
Citigroup Adjusts Price Target on DexCom to $101 From $91 -February 14, 2025 at 08:37 am EST - Marketscreener.com
Bernstein Adjusts Price Target on DexCom to $100 From $89 -February 14, 2025 at 08:33 am EST - Marketscreener.com
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.99%
0.62%
자본화:
|
볼륨(24시간):